AMINOSYN 8.5% W/ELECTROLYTES
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC
Approval overview AMINOSYN 8.5% W/ELECTROLYTES is listed in Drugs@FDA under application 017673 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC Form and strength INJECTABLE;INJECTION - 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2016-07-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMINOSYN 8.5% W/ELECTROLYTES is listed in Drugs@FDA under application 017673 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC Form and strength INJECTABLE;INJECTION - 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2016-07-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.